Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anika Therapeutics (ANIK) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Anika Therapeutics (ANIK) over the last 15 years, with Q3 2025 value amounting to 0.12%.

  • Anika Therapeutics' Return on Invested Capital fell 1600.0% to 0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12%, marking a year-over-year decrease of 1600.0%. This contributed to the annual value of 0.07% for FY2024, which is 700.0% down from last year.
  • Anika Therapeutics' Return on Invested Capital amounted to 0.12% in Q3 2025, which was down 1600.0% from 0.1% recorded in Q2 2025.
  • Anika Therapeutics' Return on Invested Capital's 5-year high stood at 0.05% during Q3 2024, with a 5-year trough of 0.22% in Q1 2022.
  • In the last 5 years, Anika Therapeutics' Return on Invested Capital had a median value of 0.04% in 2023 and averaged 0.05%.
  • In the last 5 years, Anika Therapeutics' Return on Invested Capital plummeted by -1900bps in 2021 and then surged by 1800bps in 2023.
  • Over the past 5 years, Anika Therapeutics' Return on Invested Capital (Quarter) stood at 0.01% in 2021, then tumbled by -96bps to 0.0% in 2022, then crashed by -909bps to 0.0% in 2023, then tumbled by -1918bps to 0.08% in 2024, then crashed by -52bps to 0.12% in 2025.
  • Its Return on Invested Capital stands at 0.12% for Q3 2025, versus 0.1% for Q2 2025 and 0.09% for Q1 2025.